Consensus Report: The Current Role of Self-Monitoring of Blood Glucose in Non-Insulin-Treated Type 2 Diabetes

Higher Accuracy of Self-Monitoring of Blood Glucose in Insulin-Treated Patients in Germany: Clinical and Economical Aspects

“…55 The evidence for the clinical benefit of SMBG in diabetes is increasing. 9,11,[56][57][58] The current study supports the view that SMBG is cost-effective and contrasts with some previous observations. [12][13][14]59,60 These studies, however, were criticized for not having included a structured educational and therapeutic component in response to BG values.…”

“…[12][13][14]59,60 These studies, however, were criticized for not having included a structured educational and therapeutic component in response to BG values. 56 Small sample sizes or, in case of meta-analyses, exclusion of relevant data have also been reported to be limitations. 61 Current results of SMBG studies are based on data of BG meters, which adhere to less stringent accuracy standards.…”

Effects of structured testing versus routine testing of blood glucose in diabetes self-management: A randomized controlled trial

“…However, frequent and/or regular SMBG can lead to economic barriers and have a negative impact on health care budget (Klonoff et al, 2011). The subtle relationship between cost and effects of SMBG on diabetes management has been a concern around the world.…”

5thAnnual Symposium on Self-Monitoring of Blood Glucose (SMBG) Applications and Beyond, May 3–5, 2012, Dublin, Ireland

“…That is the conclusion of a recent review on the current role of SMBG in non-insulin-treated T2D published 8 Schweitzer closed his talk by concluding that regarding the role of SMBG in current diabetes management, today there is substantial evidence to support that the MoA of SMBG is well understood and is to transfer glucose information into a medically meaningful therapy decision and action. SMBG is mandatory to achieve and maintain good glycemic control.…”